HAP: Hospital Acquired Pneumonia in Temporary Tracheostomy

Sponsor
Guy's and St Thomas' NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05418517
Collaborator
King's College London (Other)
193
1
4
48.2

Study Details

Study Description

Brief Summary

Medical condition or disease under investigation:

Oromaxillofacial surgery in head and neck cancer

Purpose of research:

Retrospective data analysis identifying hospital acquired pneumonia in patients who undergo temporary tracheostomy with oromaxillofacial surgery and free flap reconstruction

Primary objective:

Undertake an adequately powered, robustly designed observational cohort study that describes the rates of hospital acquired pneumonia in patients who undergo a tracheostomy and those that undergo overnight intubation during oromaxillofacial surgery for HNC.

Secondary objective:

To investigate whether smoking history, respiratory history (COPD, asthma) or size of tumour are associated with an increased risk of developing hospital acquired pneumonia.

Number of Subjects/Patients: 193 Study Type: Observational cohort

Main Inclusion Criteria:

Patients who underwent oromaxillofacial resection with free flap reconstruction and tracheostomy from 1st January 2018 to 31st December 2018.

Patients who underwent oromaxillofacial resection with free flap reconstruction and with overnight intubation from 1st January 2014 to 31st December 2014

Statistical Methodology and Analysis:

A power calculation has been used to determine the sample size required for statistical analysis of data. Statistical significance for rates of HAP will be tested between the two groups.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tracheostomy
  • Procedure: Overnight intubation

Detailed Description

Trial objectives and purpose

  • To select patients according to a pre-defined set of inclusion and exclusion criteria

  • Collect pre-determined quantitative data relevant to the study question using hospital medical records

  • Describe patient demographic data and explore any relationship between these and the development of a HAP

  • Asses rates of HAP using historical medical data and pre-defined criteria that identifies hospital acquired pneumonia

  • Describe rates of HAP in patients who did not have a tracheostomy inserted for maxillofacial surgery with free flap reconstruction

  • Describe rates of HAP in patients who did have a tracheostomy inserted for maxillofacial surgery with free flap reconstruction

Study Design In 2017, a new maxillofacial surgeon was appointed to Guy's & St Thomas' NHS Foundation Trust who's preference was to insert a temporary tracheostomy for all patients undergoing oromaxillofacial surgery with free flap reconstruction. Prior to this there was a wide variation in case selection with the majority of patients undergoing overnight intubation. Since subsequent practice has now changed and all patients now undergo tracheostomy insertion within OMFS, a prospective design is not possible, therefore, a single site retrospective observational design will be adopted, allowing data from two cohorts of patients identified to be collected within a feasbile timeframe dictated by the module deadlines. Electronic and paper notes of patients from cohorts before and after the change in maxillofacial surgical practice (2014 and 2018) will be screened.

Study Design

Study Type:
Observational
Anticipated Enrollment :
193 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
The Incidence of Hospital Acquired Pneumonia in Patients Who Undergo Temporary Tracheostomy With Oromaxillofacial Resection and Reconstruction for Head and Neck Cancer.
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
oromaxillofacial surgery

Patients who underwent oromaxillofacial surgery

Procedure: Tracheostomy
temporary tracheostomy insertion

Procedure: Overnight intubation
Patient who had overnight intubation

Outcome Measures

Primary Outcome Measures

  1. Hospital acquired pneumonia [7 days post surgery]

    Development of hospital acquired pneumonia according to BMJ best practice 'hospital acquired pneumonia' (non covid-19) diagnosis criteria

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All

Subject inclusion criteria

  • Patients who underwent maxillofacial resection with free flap reconstruction and tracheostomy from 1st January 2018 to 31st December 2018.

  • Patients who underwent maxillofacial resection with free flap reconstruction and with endotracheal intubation from 1st January 2014 to 31st December 2014

  • Patients over the age of 18

Subject exclusion criteria

  • Patients who did not undergo maxillofacial resection with free flap reconstruction and tracheostomy from 1st January 2018 to 31st December 2018 - not relevant and will not answer the study question

  • Patients who did not undergo maxillofacial resection with free flap reconstruction and with endotracheal intubation from 1st January 2014 to 31st December 2014 - not relevant and will not answer the study question

  • Patients under the age of 18

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guy's and St Thomas' NHS Foundation Trust London United Kingdom SE1 9RT

Sponsors and Collaborators

  • Guy's and St Thomas' NHS Foundation Trust
  • King's College London

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Rachel Wijayarathna, Highly specialist physiotherapist - head & neck oncology, Guy's and St Thomas' NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05418517
Other Study ID Numbers:
  • IRAS ID295395
First Posted:
Jun 14, 2022
Last Update Posted:
Jun 14, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2022